Michael D Macklin

Title: Michael D. Macklin: Innovator in Wound Healing Technology

Introduction

Michael D. Macklin is a notable inventor based in Middleton, WI (US). He has made significant contributions to the field of wound healing through his innovative research and development. His work focuses on utilizing genetic engineering to enhance the healing process of skin wounds.

Latest Patents

Macklin holds a patent for a groundbreaking method involving a DNA molecule that encodes a secretable mature epidermal growth factor (EGF) polypeptide. This technology allows for the delivery of the DNA construct to a skin wound, where the cells that uptake the recombinant DNA express soluble EGF. The presence of EGF has been shown to significantly accelerate the healing time of treated wounds. The genetic construction differs from the naturally occurring EGF precursor gene by retaining only the coding region for the mature EGF polypeptide, omitting the amino-terminal EGF-like repeats and the carboxy-terminal hydrophobic sequence.

Career Highlights

Macklin is currently associated with Auragen, Inc., where he continues to advance his research in wound healing technologies. His innovative approach has the potential to revolutionize treatment methods for skin injuries, providing faster recovery times for patients.

Collaborations

Macklin has worked alongside esteemed colleagues such as Elof Eriksson and Christophe Andree, contributing to a collaborative environment that fosters innovation and scientific advancement.

Conclusion

Michael D. Macklin's contributions to wound healing technology exemplify the impact of innovative thinking in the medical field. His patented methods offer promising solutions for enhancing recovery from skin wounds, showcasing the importance of research and development in healthcare.